Agilent Technologies, Inc. $A Shares Sold by Spire Wealth Management

Spire Wealth Management lowered its stake in Agilent Technologies, Inc. (NYSE:A) by 63.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,013 shares of the medical research company’s stock after selling 1,778 shares during the quarter. Spire Wealth Management’s holdings in Agilent Technologies were worth $120,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in A. Generation Investment Management LLP lifted its position in shares of Agilent Technologies by 19.8% during the first quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company’s stock worth $582,976,000 after purchasing an additional 824,243 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Agilent Technologies by 18.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock worth $448,748,000 after purchasing an additional 604,124 shares in the last quarter. Mackenzie Financial Corp lifted its position in shares of Agilent Technologies by 141.5% during the first quarter. Mackenzie Financial Corp now owns 935,893 shares of the medical research company’s stock worth $109,481,000 after purchasing an additional 548,344 shares in the last quarter. Woodline Partners LP lifted its position in shares of Agilent Technologies by 681.6% during the first quarter. Woodline Partners LP now owns 522,073 shares of the medical research company’s stock worth $61,072,000 after purchasing an additional 455,276 shares in the last quarter. Finally, Nordea Investment Management AB lifted its position in shares of Agilent Technologies by 16.2% during the second quarter. Nordea Investment Management AB now owns 3,213,748 shares of the medical research company’s stock worth $383,143,000 after purchasing an additional 447,207 shares in the last quarter. Institutional investors and hedge funds own 87.41% of the company’s stock.

Analyst Upgrades and Downgrades

A has been the topic of several research reports. Evercore ISI increased their price target on shares of Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 7th. Robert W. Baird increased their price target on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a research report on Thursday, August 28th. Wells Fargo & Company raised their target price on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an “overweight” rating in a report on Monday, September 15th. Rothschild & Co Redburn started coverage on shares of Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 target price on the stock. Finally, UBS Group raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and raised their target price for the company from $130.00 to $170.00 in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $149.62.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $146.46 on Wednesday. The firm has a market capitalization of $41.52 billion, a P/E ratio of 34.38, a P/E/G ratio of 4.67 and a beta of 1.26. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. The firm’s 50 day moving average is $134.05 and its two-hundred day moving average is $121.62.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting the consensus estimate of $1.37. The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The firm’s revenue was up 10.1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Research analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th were paid a $0.248 dividend. This represents a $0.99 annualized dividend and a yield of 0.7%. The ex-dividend date was Tuesday, September 30th. Agilent Technologies’s dividend payout ratio is currently 23.24%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.